Dubai Healthcare City unveils AI Pharmacy & Longevity Clinic at World Health Expo 2026

UAE—Dubai Healthcare City (DHCC) has revealed plans to significantly expand its longevity and pharmaceutical services at the World Health Expo Dubai 2026, marking a major step forward in the emirate’s integrated healthcare landscape.

The expansion centers on two key developments: a comprehensive longevity-focused preventive care program and the region’s first AI-powered tele-compounding pharmacy platform.

These additions aim to deliver more personalized care while emphasizing long-term wellness, clinical oversight, and precision medicine.

The move positions DHCC as a healthcare destination that’s actively adapting to global shifts in how medical care is delivered and customized.

Building infrastructure for next-generation care

Rashed Ahmed Alawadhi, Director of Property Management at Dubai Healthcare City Authority, emphasized the importance of creating an environment that supports modern healthcare delivery.

 “Our role is to ensure that the physical and operational environment supports the next generation of healthcare delivery,” he said.

Alawadhi explained that adding longevity services alongside advanced pharmaceutical models like AI-driven tele-compounding shows how DHCC’s infrastructure is evolving to accommodate specialized, precision-focused care.

By developing fit-for-purpose facilities and integrated spaces, DHCC enables healthcare providers to operate efficiently, scale their services responsibly, and deliver high-quality outcomes.

Proto Clinic brings personalized longevity medicine

Proto Clinic is leading DHCC’s longevity initiative with a science-based program designed to extend healthspan and improve quality of life.

The program combines advanced diagnostics, genomics, lifestyle medicine, and continuous monitoring to create highly individualized longevity pathways for patients.

This approach reflects a growing global trend as aging populations increasingly seek preventive, personalized strategies for long-term health management.

By partnering with Proto Clinic, DHCC strengthens its reputation as a hub for forward-thinking preventative healthcare.

Dr. Wissam Adada, Founder and Chairman of Proto Clinic, described the philosophy behind longevity medicine.

“Longevity medicine requires a shift from reactive treatment to a clinically grounded, preventive approach tailored to each individual,” he noted.

 At Proto Clinic, the team combines advanced diagnostics, genomics, and lifestyle medicine to deliver personalized longevity pathways backed by a decade of clinical practice and multidisciplinary expertise.

Operating within DHCC’s ecosystem allows the clinic to maintain high clinical standards in a regulated, innovation-friendly environment.

AI-Driven personalized pharmacy

Alongside its longevity offerings, DHCC has launched The Formula, the Middle East’s first AI-driven tele-compounding pharmacy platform.

This groundbreaking service enhances access to precision therapies through an innovative digital approach.

The Formula integrates clinical intelligence, pharmaceutical-grade compounding, and advanced AI decision-support into one secure digital workflow.

Patients can now access custom-compounded medications with personalized dosages through a complete pathway that includes digital consultation, AI-enhanced clinical assessment, bespoke formulation, and regulated fulfillment.

The platform assists clinicians with decision-support tools while keeping medical judgment at the center of care, ensuring personalized therapies are delivered safely and efficiently.

Ameera Youssef, Chief Executive Officer of Acorn Research and Co-founder of The Formula, highlighted the platform’s significance.

“The launch of The Formula within DHCC marks a significant milestone for personalized pharmaceutical care in the region,” she explained.

By combining AI-supported clinical insight with regulated compounding pharmacy workflows, the platform is redefining how customized medicines are prescribed, prepared, and monitored while keeping patient safety and clinical governance as top priorities.

Supporting Dubai’s Healthcare Vision

These announcements come as DHCC participates in World Health Expo Dubai 2026, showcasing the maturity of its ecosystem amid rising global demand for integrated healthcare destinations that unite longevity, pharmaceutical innovation, wellness, and digital health.

Through ongoing expansion of its longevity and advanced pharmaceutical capabilities, DHCC provides a regulated, innovation-ready platform for healthcare providers delivering precision medicine at scale, supporting Dubai’s ambition to lead in healthcare and life sciences.